Drugs / Nitric Oxide Nasal Spray
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06264141 Comparator | Jan 2024 → Feb 2025 | sinusitis | Sanotize Research and Development corp. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitric Oxide Nasal Spray | “Nitric Oxide Nasal Spray” NCT06264141 ↗ |
| Known as | Nitric Oxide Releasing Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06264141 ↗ |
| Route | Intranasal | “Nasal spray with nitric oxide releasing solution (NORS) delivered five times per day” NCT06264141 ↗ |